Drug recall
Red Blood Cells, Leukocytes Reduced
FDA recall event 85971 · Class II · American Natl. Red Cross-Greater Chesapeake & Potomac Region
Key facts
| Event ID | 85971 |
|---|---|
| Recall numbers | B-0575-2020 |
| Recalling firm | American Natl. Red Cross-Greater Chesapeake & Potomac Region |
| Product type | Biologics |
| Products | Red Blood Cells, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Red Blood Cell product, collected from an unsuitable donor due to a donor screening deviation, was distributed. |
| Initiation date | Feb 19, 2020 |
| Report date | Jul 15, 2020 |
| Termination date | Jul 8, 2020 |
| City | Baltimore |
| State | MD |
| Country | United States |
| FEI number | 1173011 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: